Inicio>>Signaling Pathways>> Microbiology & Virology>> RSV>>Pentaacetylquercetin

Pentaacetylquercetin (Synonyms: NSC 115919, Peracetylated Quercetin, Quercetin Pentaacetate)

Catalog No.GC40189

La pentaacetilquercetina podrÍa interactuar con la proteÍna F con menor energÍa de uniÓn y mejor estabilidad para bloquear la adhesiÓn viral.

Products are for research use only. Not for human use. We do not sell to patients.

Pentaacetylquercetin Chemical Structure

Cas No.: 1064-06-8

Tamaño Precio Disponibilidad Cantidad
10mg
66,00 $
Disponible
50mg
213,00 $
Disponible
100mg
358,00 $
Disponible
500mg
1.627,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pentaacetylquercetin is a pentaacetylated derivative of the flavonoid quercetin that has diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties. It scavenges 2,2-diphenyl-1-picrylhydrazyl radicals in vitro (IC50 = 3.74 μg/ml) and inhibits iron(II) chloride-induced lipid peroxidation in rat liver mitochondria (IC50 = 20.2 μg/ml). Pentaacetylquercetin inhibits LPS-induced increases in nitrite (IC50 = 8.7 μM) and PGE2 production, as well as inducible nitric oxide synthase (iNOS) and COX-2 levels, in RAW 264.7 cells when used at concentrations of 20 and 40 μM. It also inhibits the growth of HL-60, U937, and SK-MEL-1 cells (IC50s = 38, 25, and 58 μM, respectively).

Reseñas

Review for Pentaacetylquercetin

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pentaacetylquercetin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.